Non-ownership Filings
| HUTCHMED to Receive Milestone Payment from Takeda | Dec. 13, 2024 |
| Breakthrough Therapy Designation in China | Dec. 12, 2024 |
| HUTCHMED and Innovent Announce ELUNATE Approval | Dec. 03, 2024 |
| Total Voting Rights | Nov. 29, 2024 |
| Continued Inclusion of ORPATHYS in China NRDL | Nov. 28, 2024 |
| FRUZAQLA® Launched in Japan by Takeda | Nov. 22, 2024 |
| Appointment of Independent Non-executive Director | Nov. 20, 2024 |
Ownership Update Filings
| Vesting of awards under the LTIP | Oct. 21, 2024 |
| Standard form for notification of major holdings | Aug. 22, 2024 |
| LTIP and Share Option Scheme | Aug. 06, 2024 |
| Vesting of Awards Under the LTIP | Apr. 22, 2024 |
| LTIP and Share Option Scheme | Mar. 14, 2024 |
| Vesting of awards under the LTIP | Mar. 05, 2024 |
| Vesting of awards under the LTIP | Oct. 24, 2023 |